Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2020 | 99mTc-DPD scintigraphy predicts amyloid fibril type in ATTR amyloidosis

Jonas Wixner • 18 Sep 2020
ISA 2020
Amyloidosis Rare Diseases

Jonas Wixner, MD, PhD, Umeå University, Umeå, Sweden, discusses his ISA 2020 talk on 99mTc-DPD scintigraphy and how it predicts amyloid fibril type in hereditary transthyretin (ATTR) amyloidosis. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals